Molecular profile of bladder cancer progression to clinically aggressive subtypes

Charles C. Guo(The University of Texas MD Anderson Cancer Center), Bogdan Czerniak(The University of Texas MD Anderson Cancer Center), Michael Zaleski(The University of Texas MD Anderson Cancer Center), Woonyoung Choi(Johns Hopkins University), David J. McConkey(Johns Hopkins University), Sangkyou Lee(The University of Texas MD Anderson Cancer Center), June G. Lee(The University of Texas MD Anderson Cancer Center), Huiqin Chen(Soochow University), Peng Wei(Creighton University)
Nature Reviews Urology
February 6, 2024
10.1038/s41585-023-00847-7
Cited by 86

Related Papers

Comprehensive molecular characterization of urothelial bladder carcinoma
|Nature|2014|3.1k
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
|Cell|2017|2.5k
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
|European Urology|2019|1.4k
Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies
|Human Molecular Genetics|2014|1.2k
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|798